|
ULTRAVIST® (iopromide) injection is a world-class nonionic, iodinated, low osmolar radiological contrast agent for intravascular administration. ULTRAVIST was initially introduced in Europe in 1985, and has been available in the US since 1995.
- Clinical experience in over 100 million patients
- Proven safe and effective in all major I.A. and I.V. indications
- A well-tolerated, low osmolality contrast agent
- A low viscosity contrast agent enables ease of administration and rapid iodine delivery rate
- 4 concentrations, ranging from 150 to 370 mgI/mL, which is the highest commercially available iodine concentration
- Available in a variety of vial sizes, including the 500 mL Pharmacy Bulk Package
- Packaged for safety and convenience including:
- Color-coded vials for easy identification of concentration
- Clear glass vials/bottles for examination of product's clarity
- Peel-off product identification labels to help maintain JCAHO Standard In Labeling Guidelines
ULTRAVIST®(iopromide) injection:
All nonionic, iodinated contrast media currently available inhibit blood coagulation in vitro less than ionic contrast media. Clotting has been reported when blood remains in contact with syringes containing nonionic contrast media. Therefore, meticulous intravascular administration technique is necessary to minimize thromboembolic events. As with all iodinated contrast agents, serious or fatal reactions have been associated with their use. ULTRAVIST injection is not indicated for intrathecal use.
|
